| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 8 Sep 2025 | 2 Sep 2025 |
| Inter alia to transact the following business: 1. To ascertain director, who shall be liable to retire by rotation; 2. To approve Boards Report along with all its Annexures including Management Discussion and Analysis Report, Secretarial Audit Report and Corporate Governance Report for the Financial Year 2024-25; 3. To fix day, date and time of 34th Annual General Meeting of the Company and to approve the Notice of Annual General Meeting; 4. To fix Book Closure period for 34th Annual General Meeting of the Company; 5. To appoint Scrutinizer to conduct remote Voting Process as well as Evoting at 34th Annual General Meeting of the Company; 6. To appoint Secretarial Auditor of the Company for the term of five years from F.Y. 2025-26 to F.Y. 2029-30; 7. To appoint Internal Auditor of the Company; 8. To appoint Statutory Auditor of the Company; 9. To appoint Cost Auditor of the Company; 10.Other ancillary and routine businesses. | ||
| Board Meeting | 14 Aug 2025 | 12 Aug 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve the Standalone Unaudited Financial Results for the Quarter ended 30th June 2025. | ||
| Board Meeting | 11 Aug 2025 | 6 Aug 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider and approve other businesses. Intimation of Board Meeting to be held on Monday (As Per BSE Announcement Dated on: 11.08.2025) | ||
| Board Meeting | 26 Jul 2025 | 22 Jul 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2025 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Sarda Proteins Limited is scheduled to be held on Friday July 26 2025 at 11:00 A.M. through Video Conferencing at the registered office of the Company inter alia to consider and approve the following matters: 1. To consider and approve the appointment of Ms. Rinkal Malviya as Woman Director (Executive Director) on the Board of the Company; 2. Proposal for change in the name of the Company from Sarda Proteins Limited to Onix Power Limited; 3. Proposal for shifting of the registered office of the Company. 4. To approve Notice of Extra-Ordinary General Meeting of the Company through Video Conferencing 5. To appoint Scrutinizer and E-voting Agency for the E-voting/ Remote e-voting process of the Company | ||
| Board Meeting | 15 May 2025 | 12 May 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve Intimation of Board Meeting Outcome of Board Meeting held today i.e., 15-05-2025 (As Per BSE Announcement Dated on: 15.05.2025) | ||
| Board Meeting | 8 Apr 2025 | 8 Apr 2025 |
| Outcome of Board Meeting held today i.e, 8th April, 2025 | ||
| Board Meeting | 17 Jan 2025 | 13 Jan 2025 |
| SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2025 inter alia to consider and approve Unaudited financial results for the quarter and nine months ended on 31st December 2024. The Board of Directors approved the unaudited financial results for the quarter and nine months ended on 31st December 2024. (As Per BSE Announcement dated on 17.01.2025) | ||
| Board Meeting | 24 Dec 2024 | 18 Dec 2024 |
| SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/12/2024 inter alia to consider and approve proposal for fund raising through issue of fresh Equity Shares and / or Convertible Warrants. Outcome of Board Meeting (As Per Bse Announcement Dated on 24.12.2024) | ||
| Board Meeting | 8 Nov 2024 | 26 Oct 2024 |
| SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended on 30th September 2024. The Board of Directors approved the unaudited financial results for the quarter and half year ended on 30th September 2024 in their Board Meeting held today, 8th November 2024. The Board Meeting started at 6.00 pm and was concluded at 7.00 pm on the same day. (As Per BSE Announcement Dated on: 08/11/2024) | ||
| Board Meeting | 26 Oct 2024 | 26 Oct 2024 |
| Appointment of Company Secretary and Compliance officer. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.